Introduction. The use of probiotics demonstrate efficacy against obesity and metabolic syndrome (MetS). Detection effective probiotic strains for hyperglycemia and immunity associated with is important task.
Introduction
Obesity is a major risk factor for the development of type 2 diabetes mellitus (T2DM) and being more than doubled during the last 30 years, is considered to be the most important health problem globally [1] [2] [3] [4] [5] .
Metabolic syndrome (MetS) is a common, associated with profound violation of metabolic processes in the human body, and include development of diabetes mellitus (DM), cardiovascular (coronary heart disease, atherosclerosis, arterial hypertension) and hepatobiliary diseases (gallstone disease, bile dyskinesia, chronic cholecystitis), pathology of the musculoskeletal system, as well as several types of cancer and premature death [1] .
The diagnosis of "metabolic syndrome" can be made if at least three of the following five criteria [2] are met:
 obesity with abdominal fat distribution, determined by an abdominal circumference of over 102 cm in men or over 88 cm in women;
 dyslipidemia (increasing Serum triglycerides greater than 150 mg/dL (>1.7 mmol/L);  high density lipoprotein (HDL) cholesterol ≤ 40 mg/dL;  hypertension of 130/85 mmHg or more;
 and fasting blood sugar ≥ 110 mg/dL (5.6 mmol/L), or type 2 diabetes mellitus (T2DM).
Abdominal obesity most often occurs as a result of increased energy consumption with food, uncontrolled use of nutritional supplements, low levels of physical activity and genetic predisposition. The complex relation of obesity/overweight and DM as well as their associations with the microbiome has been demonstrated [2] [3] [4] [5] . Microbiome is highly variable and a very important player mutually related to DM as well as obesity, e.g., weight gain may be also considered as a complication of insulin treatment [5] . Dietary intervention was found to modulate the gut microbiota and improve glucose control in individuals with T2DM [6] .
The role of immunity the development of inflammatory processes in diabetes type 1 and 2 and all aspects of metabolic disorders of obesity, have been extensively discussed and different immunity patterns switch on during both diabetes type 1 and 2 during the modification of gut microbiota have been hypothesized [7] [8] [9] [10] .
Thus, in type 1 diabetes mellitus, the lowered expression of adhesion proteins within the intestinal epithelium favours a greater immune response that may result in destruction of pancreatic β cells by CD8+ T-lymphocytes, and increased expression of interleukin(IL)-17, related to autoimmunity [8] .
The relationship between lipopolysaccharides (LPS) and the development of T2DM has been observed in some clinical trials [9] . The cytokine-induced inflammatory or acute-phase response hypothesis claims that T2DM and the MetS are associated with proinflammatory cytokine IL-6 and acute-phase reactants such as C-reactive protein [10] . The gut microbiota benefits humans via short-chain fatty acid (SCFA) production from carbohydrate fermentation, and deficiency in SCFA production is associated with T2DM. Targeted restoration of these SCFA producers may present a novel ecological approach for managing T2DM [11] .
On the other hand, it has been proven that both the high-fat as well as carbohydrate-rich diet are independent factors causing the reduction of the number of Bacteroidetes and the increase of the Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 8 August 2018 doi:10.20944/preprints201808.0169.v1 amount of Firmicutes [12] . The relative raise of Firmicutes in response to a fat-dominant diet has been described in both mice and human observations [12] .
The pathophysiological mechanisms of obesity can involve a number of neuroimmunodecrine disorders [13, 14] .
The development of chronic systemic inflammation, dysfunction of specific hypothalamic neurons, and activation of the hypothalamic-pituitary-adrenal axis during obesity cause disturbances in the control of body weight in the lipostat system. In obese patients, with the low level of adiponectin, products of leptin and proinflammatory cytokines increase adipocytes of adipose tissue, which in turn activates the production of IL-1β, IL-6, tumor necrosis factor-α (IFN-α), interferon-γ and chemokines by the cells of the immune system.
Proinflammatory cytokines affect the activity of adipocytes, lipolysis, insulin reaction, glucose metabolism and adipokine production, which results in fat deposition and systemic chronic inflammation [13, 14] . Activation of proinflammatory cytokines is considered to be the main factor in the development of resistance to insulin and hyperlipidemia [14] .
Clinical data originating from several meta-analyses of randomized controlled trials (RCTs) [15] [16] [17] [18] [19] [20] confirm that probiotics may have beneficial effects for diabetes, especially for T2DM patients.
Consuming probiotics may improve glucose metabolism by a modest degree, with a potentially greater effect when the duration of intervention is ≥8 weeks, or multiple species of probiotics are consumed [15] .
The findings by Horvath et al. [18] explain the beneficial effects of probiotics on immune function via increased serum neopterin levels and the production of reactive oxygen species by neutrophils to improve liver function in cirrhosis.
A meta-analysis of RCTs by Jun et al. [19] stated that application of probiotics may decrease the lipid profile indexes, blood pressure, and fasting blood glucose (FBG) in patients with T2DM and can be a new method for lipid profiles and blood pressure management in T2DM [19] .
The by Wang et al. [20] concluded that probiotics may have beneficial effects on the reduction of glucose, insulin and HbA1c for diabetes, especially for T2DM mellitus patients.
The limitations of completed RCTs [15] [16] [17] [18] [19] [20] have been notes to be as follows [19, 20] : differences in the inclusion criteria and exclusion criteria for patients; different patients with previous disease and treatments were unavailable; most trials with low quality and low Jadad score; pooled date used for analysis, and unavailable individual patients' data. It was suggested that improvement a quality of clinical trials urgently needed and it would require to consider all known potential biases, update the list periodically, and score the trial by multiplying (not adding) the component scores with regard to risks of potential bias to obtain an overall score, etc. [21] .
Probiotics have are great potential for many aspects of MetS and immunity [22] [23] [24] [25] . Thus, recently
we have studied efficacy of use of probiotic for pillar conditions of MetS, namely obesity, dyslipidemia and liver dysfunction, and also for modifying gut microbiota [25] and against glutamate-induced and immune-mediated obesity [12] and the potential for individualized use according to strain-specific probiotic properties has been recently studied [26] .
We have previously found that the original probiotic strains of lactic acid bacteria (LAB) and also demonstrate high levels of antagonistic activity against pathogenic and opportunistic bacteria
[27], the resistance to aggressive conditions of the gastrointestinal tract, high or moderate adhesion to the cells of the epithelium of the gastrointestinal mucosa [26] and immunomodulatory properties associated with bacterial wall structure [28] .
On different models of experimental obesity in animals it has been proved that they improved the metabolism and modified the intestinal microbiota. The most effective were L. casei IMV B-7280 and composition L. casei IMV B-7280 / B. animalis VKB / B. animalis VKL [14, 25] .
The probiotic strain L. casei IMV B-7280 in recent studies demonstrated most pronounced beneficial effect for most applications.
Therefore, we have set this study to in order finalize the puzzle to study effects of mentioned strains against conditions that constitute MetS.
The aim of the study was to evaluate the effect of probiotic strain L. casei IMV B-7280
(separately) and in composition L. casei IMV B-7280 / B. animalis VKB / B. animalis VKL on the level of glucose in blood and also inflammatory response (inflammation) on the experimental obesity in mice, induced by a diet enriched with fats (FED).
Materials and Methods

Animals
Experimental study was carried out on BALB/c male at the age of 6-8 weeks ( No human subjects were included to the study.
Bacteria and culture conditions
We used original probiotic strains of LAB and bifidobacteria -L. casei IMV B-7280, which is VKB. The studies were conducted using bacteria freeze dried in Cuddon Freeze Dryer FD1500 (New Zealand). Prior to each experimental study, the activity of these freeze-dried probiotic bacteria was checked by control of their growth on a Man-Rogosa-Sharpe Agar or Bifido Agar medium (Merck, Germany) at 37 °C during 24-48 hours.
Design of the experiment
The experimental model of FED-induced obesity in mice, previously developed by [25] , was used in 1) orally at a dose of 5 x 10 6 cells. / animal every day during 10 days. To reproduce the rational therapeutic scheme, these mice were transferred to a regular diet.
Mice were divided into 5 groups of 6 animals each: intact mice receiving the regular diet (control) (Group I); mice receiving FED (Group II); mice with obesity, transferred to a regular diet, and were not given probiotic strains (Group III); obese mice transferred to the regular diet that received L. casei
Mice were weighed weekly. The viability of blood from the caudal vein of mice to determine the level of glucose was carried out prior to the beginning of the FED and at 7, 14, 21, 28, 35, 45 and 52 days of observation. Serum was received from the blood, and was stored at -20 °C before the experimental studies were performed. At 52 days mice were killed by cervical dislocation after complete anesthesia, visceral fat was removed from the abdominal cavity and weighed.
Glucose measurements
To determine the blood glucose content, the Glucometer FreeStyle Optium NEO (Abbot Diabetes Care Ltd (England)) was used.
Cytokines production measurements
The concentration of TNF-α in serum was determined using the enzyme-linked immunosorbent assay (ELISA) using the immunoassay system Thermo Fisher Scientific Inc. (Bender MedSystems GmbH, Austria) according to manufacturer's recommendations and expressed in pg / ml.
Macrophages harvest
On the 52 day after the probiotic bacteria injection, a fluid was collected from the peritoneal cavity in mice of all groups that were killed by cervical dislocation after complete anesthesia. The cooled culture medium 199 was injected into the abdominal cavity, and after the soft massage of the abdomen, the abdominal fluid was collected by aspiration. Peritoneal exudate cells were centrifugated three times 10 min at 400 × g.
The precipitate was then resuspended in a cold culture medium RPMI-1640, which was added to 10 jetting chilled RPMI-1640 into the cells and counted using Goryaev's chamber. A suspension of PEMs was prepared in RPMI-1640 with 10 % fetal calf serum, 50 μg / ml gentamicin and 1M Hepes in a quantity of 5 × 10 7 cells / ml.
Respiratory burst and phagocytic activity measurements
Respiratory burst activity (RBA) of PEMs was evaluated using a spontaneous and stimulated nitro-blue tetrazolium (NBT) reduction test [30] .
The principle of this method is the restoration of NBT in the PEMs cytoplasm to formazan under the influence of the superoxide anion formed during cell activation. Formazan has the appearance of dark blue granules, the number of which varies depending on the severity of the oxygen explosion.
The advantage was given to the cytochemical record of the results, based on the мicroscopic examination and counting of the percent NBT-positive (formazan-containing) PEMs. Briefly, in a spontaneous NBT test, 100 μl suspension of PEMs (5 x 10 7 cells / ml), 100 μl of 0.1 % NBT (Sigma, USA) in PBS and 100 μl of PBS were applied to the substrate and incubated at 37 °C for 2 hours in an atmosphere of 5 % CO2. In the stimulated NBT test, 100 μl of suspension of PBS by daily culture of Staphylococcus aureus strain 8325-4 (inactivated by heating at 57 °C for 30 min) at a concentration of 5 x 10 9 cells / ml was introduced into the PEMs. After cultivation, PEMs was washed twice with PBS, сarefully dried, fixed with methanol and stained with 1 % safranin solution. In the field of view of the microscope, 100 or more cells were counted, the percent NBT-positive of PEMs was determined.
The difference between the indices of the spontaneous and stimulated NBT test was calculated by the PEMs functional reserve (FR).
The phagocytic activity of PEMs was determined using latex beads (1.1 μm, Sigma, USA)
microscopically [2] . Briefly, a 100 μl suspension of PEMs (5 x 10 7 cells / ml) and a suspension of latex particles in PBS was applied to the substrate and incubated at 37 °C for 2 hours in an atmosphere of 5 % CO2. After that, PEMs was washed twice with PBS, сarefully dried, fixed with methanol and stained with Giemsa. A total of 100 or more PEMs were calculated and determined the Phagocytic index (PI) as the number of phagocytic cells (in %) and phagocytic number (PN) -the average number of latex particles phagocyted by a single PEM (presented in units).
Statistics
The received digital data was processed using the computer program STATISTICA. The zero hypothesis for the control and experimental groups was checked with non-parametric Kolmogorov-Smirnov test. The data was represented as M ± Std.Dev. The difference between the indicators was considered statistically significant at P <0.05.
Results
At day 7 from the beginning of FED in mice, observed the change in behavioral reactions: mice became sluggish, their response to external stimuli decreased, and the body temperature increased.
At the 14 th and 21 st day, we detected a tendency to increase their weight, however, the difference compared with the values for intact mice (controls) was insignificant ( animalis VKL, the weight of obese mice decreased to the level of control indices, however, there was no probable difference from mice, which continued to consume FED (Table 1) . After administration of L. casei IMV B-7280 (separately) or this probiotic composition to obese mice, the weight of the visceral fat was reduced during 52 days according to 366.8 ± 17.8 and 343.0 ± 89.5 mg / animal relative to the mice, who continued to consume FED (P < 0.05), but remained higher than control (P < 0.05). Notes: • -P < 0.05 vs indices of intact mice; * -P < 0.05 vs parameters before FED (day 0).
Note that similar results were obtained when weighing of the visceral fat in mice with obesity, translated into a regular diet, which did not enter probiotic bacteria (Table 1 ). The weight of the visceral fat in these mice was also higher than vs the controls (358.0 ± 65.4 mg / animal, P < 0.05),
although it decreased compared with the mice that continued consumimg FED (P < 0.05).
The blood glucose levels were measured as normal only in obese mice injected with L. casei IMV B-7280 (Fig. 2) . Under the influence of L. casei IMV B-7280 / B. animalis VKB / B. animalis VKL composition, the blood glucose level in obese mice did not recover to the control level, although there was a tendency to decrease this parameter. Hyperglycemia was stored in obese mice transferred to a regular diet that did not receive probiotic bacteria. Consequently, the transfer of obese mice to the regular diet did not have a significant effect on the level of blood glucose.
Also hyperglycemia in mice with obesity was associated with the development of inflammation at the systemic level: a slight increase in serum TNF-α levels was observed for 35 and 52 days of observation compared to controls (Fig. 2) . animalis VKL composition demonstrated an antiinflammatory effect in obese mice. So, under conditions of their therapeutic treatment, mice with obesity observed normalization of the serum TNF-α levels (Fig. 2) . Instead, in obese mice transferred to the regular diet, without treatment with probiotic bacteria, there was observed a tendency to decrease the levels of TNF-α in serum, but the difference compared to obese mice that continued to consume FED and controls was insignificant.
Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted
Probably, the reflection of the development of the systemic inflammation to FED-induced obesity in mice we found a hyperactivation of oxygen-dependent bactericidal activity of PEMs against the background of violations of their ability to absorb latex particles and the depletion of reserve capabilities of intracellular systems, which may predispose chronic inflammation and increased sensitivity to the development of infectious and other illnesses.
As it is shown in table 2 (table 2) . Instead, in obese mice transferred to the regular diet that did not receive probiotic bacteria, yet there was a detected the normalization of phagocytic activity of the PEMs, but the NBT test values remained significantly higher than in the control. There was also absent the FR of the PEMs of these mice. It has been proven that probiotics based on strains of LAB, representatives of commensal intestinal microbiota, can reduce body weight and improve obesity biomarkers such as hyperglycemia, dyslipidemia and inflammation [31] .
According to the literature data, chronic hyperglycemia can trigger lipid peroxidation, decrease the stability of the antioxidant system, and damage the vascular endothelium [32, 33] , resulting in increased levels of proinflammatory cytokine, like TNF-α and other markers of systemic inflammation in the blood, as well as the functional activity of macrophages [34] [35] [36] [37] [38] . Since the level of TNF-α excretion is characterized by a clear positive correlation with the degree of obesity and insulin resistance, the correction of products of this proinflammatory cytokine is considered by many researchers as a promising therapeutic approach to the treatment of obesity and insulin resistance [34] . This is explained by the fact that increased intestinal permeability due to the disturbance of the intestinal microbiota spectrum enhance penetration of LPS of gram-negative bacteria into the blood, liver and adipose tissue, where they are recognized by the Toll-and NOD-like receptors expressed on macrophages and dendritic cells, activating the innate immune response and initiate the development of inflammation, being involved in the pathophysiology of obesity and the formation of insulin resistance. Increasing the LPS content in the blood for obesity correlated with the activation of products of TNF-α and other proinflammatory cytokines [35] .
LPS triggers a strong proinflammatory reaction in colonic macrophages and secretion of proinflammatory cytokines that include TNF-α, interferon-γ, and IL-1β, whereas antiinflammatory cytokines IL-10 and IL-17 decrease and restore the intestinal permeability [36] .
Commensal microbiota were reported induce hyporesponsiveness to LPS via the production of IL-10 [37] . A randomized controlled clinical trial by Mohamadshahi et al [38] showed that consumption of probiotic yogurt for 8 weeks improved lipid profile in type 2 diabetic patients induced a significant decrease in HbA1c accompanied by reduction levels of proinflammatory cytokine TNF-α.
On the other hand, in current study the normalization of blood glucose and TNF-α production was not observed in obese mice transferred to a regular diet, and not treated with probiotic bacteria, although their weight loss was detected, the weight of the visceral fat reduced, and the partial restoration of the functional activity of PEMs. We believe that the change in the spectrum of gastrointestinal microbiota plays a key role in the implementation of the anti-inflammatory action of L. casei IMV B-7280 (separately) and L. casei IMV B-7280 / B. animalis VKB / B. animalis VKL composition for FED-induced obesity in mice. As is well-known, its imbalance, arising from the consumption of a HFD and more often found in the increase in the number of Firmicutes, Proteobacteria and in the reduction of LAB, is also one of the causes of systemic chronic inflammation [39] .
Previously, we have found [25] Number of studies demonstrate that other probiotic strains of LAB and bifidobacteria had a strain-dependent therapeutic effect on FED-induced obesity in mice of different genetic lines [40] [41] [42] [43] [44] .
Thus, the effectiveness of the strains, such as L. acidophilus AD031, B. bifidum BGN4 and B. longum BORI, was reduced by the following: weight of mice (B. longum BORI), triglycerides (B. bifidum BGN4 and L. acidophilus AD031) and total cholesterol (B. longum BORI), as well as morphological manifestations of liver steatosis [40] . Introduction L. acidophilus NS1 to obese mice was due to a decrease in the level of total cholesterol and cholesterol of low density lipoprotein [41] , and L.
acidophilus NCDC was a modification of the composition of the intestinal microbiota [42] . When L.
plantarum K21 was used in blood plasma of obese mice, the level of leptin, cholesterol and triglycerides decreased; decreased the intensity of liver damage and increased the number of Lactobacillus spp. and Bifidobacterium spp in the gastrointestinal tract [43] . Probiotic strains L.
curvatus HY7601 and L. plantarum KY1032 prevented fat accumulation in obese mice, reduced their weight, as well as insulin, leptin, and total cholesterol levels in blood plasma, modified intestinal microbiota and suppressed the expression of genes of proinflammatory molecules (TNF-α, IL-6, IL-1β, etc.) in adipose tissue [44] .
It has been shown that Bifidobacterium spp. improved homeostasis of glucose in mice, reduced the levels of accumulation of fat and reduced insulin secretion in FED-induced obesity model. Under the influence of B. breve B-3, the weight of obese mice and the accumulation of visceral fat decreased with a decrease in total cholesterol, glucose and insulin in serum [45] . Following the introduction of C. pseudocatenulatum CECT 7765 obesity mice, changes in expression of key genes involved in regulation of energy metabolism and lipid transport were detected [46] . influence of these probiotic bacteria were also: normalization of lipid and carbohydrate metabolism, the state of the antioxidant system and mitigation of inflammation processes. The more effective treatment effect of obesity caused by sodium glutamate was the L. casei IMV B-7280 / B. animalis VKB / B. animalis VKL composition [14] , while in FED-induced obesity in mice -L. casei IMV B-7280 (separately), which is probably due to the pathophysiological features of the development of these diverse types of obesity.
Novel insights & future outlooks
Recent findings can initiate reconsidering strategies for probiotic therapies.
Thus, according to `Developmental Origins of Health and Disease` (DOHaD) hypothesis [47] infant microbiota alterations due to colonisation from obese mothers may lead to increased risk of childhood obesity and diabetes [48] . The maternal gut microbiome is the source of the majority of transmitted strains shaping the early microbial diversity in the infant gut [49] . This provides novel insights for earliest prevention of MetS via targetting mother`s gut microbiome.
Dead bacteria might also improve diabetic profiles. Thus, the study by Kikuchi et al. [50] indicates that sterilized bifidobacteria suppressed fat accumulation, improved insulin resistance, and lowered blood glucose levels in mice on a high-fat diet.
Current model of obesity may corresponds to MetS model according to the definition [2] and consequently this study completes an agenda on the research strategy for metabolic syndrome treatment with probiotics since studied strains: reduce obesity and visceral fat [14, 25] , improve dyslipidemia [25] , and re-equilibrate glycemic and inflammatory profiles in obesity according to the results of current study.
The "single strain" concept could be preliminary considered, since the probiotic strain L. casei IMB B-7280 has been demonstrated to be most effective in decreasing glucose and serum TNF-α levels than composition of the probiotic strains.
Therefore it is promising for the development of probiotics of multifactorial actions that can be used for the prevention of obesity and personalized treatment of patients with MetS and DM.
On the other hand individualized approach should be carefully considered for personalized dietary and probiotic therapy for obese patients, as well as to set preventive programs, taking into account patient`s individual profiles: age, sex, spectrum of intestinal microbiota, immune system status , nutritional habits, etc.
Further research should aim study the effectiveness vs currently established efficacy for the identification of new effective compositions of probiotic strains of bacteria, the selection of optimal treatment schemes and rational dosage.
Conclusions
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